Literature DB >> 25051958

A calcineurin- and NFAT-dependent pathway is involved in α-synuclein-induced degeneration of midbrain dopaminergic neurons.

Jing Luo1, Lixin Sun2, Xian Lin2, Guoxiang Liu2, Jia Yu2, Loukia Parisiadou2, Chengsong Xie2, Jinhui Ding3, Huaibin Cai4.   

Abstract

Parkinson's disease (PD), the most common degenerative movement disorder, is caused by a preferential loss of midbrain dopaminergic (mDA) neurons. Both α-synuclein (α-syn) missense and multiplication mutations have been linked to PD. However, the underlying intracellular signalling transduction pathways of α-syn-mediated mDA neurodegeneration remain elusive. Here, we show that transgenic expression of PD-related human α-syn A53T missense mutation promoted calcineurin (CN) activity and the subsequent nuclear translocation of nuclear factor of activated T cells (NFATs) in mDA neurons. α-syn enhanced the phosphatase activity of CN in both cell-free assays and cell lines transfected with either human wild-type or A53T α-syn. Furthermore, overexpression of α-syn A53T mutation significantly increased the CN-dependent nuclear import of NFATc3 in the mDA neurons of transgenic mice. More importantly, a pharmacological inhibition of CN by cyclosporine A (CsA) ameliorated the α-syn-induced loss of mDA neurons. These findings demonstrate an active involvement of CN- and NFAT-mediated signalling pathway in α-syn-mediated degeneration of mDA neurons in PD. Published by Oxford University Press 2014. This work is written by (a) US Government employee(s) and is in the public domain in the US.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25051958      PMCID: PMC4240205          DOI: 10.1093/hmg/ddu377

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  40 in total

1.  Overexpression of human alpha-synuclein causes dopamine neuron death in rat primary culture and immortalized mesencephalon-derived cells.

Authors:  W Zhou; M S Hurlbert; J Schaack; K N Prasad; C R Freed
Journal:  Brain Res       Date:  2000-06-02       Impact factor: 3.252

Review 2.  Calcineurin: form and function.

Authors:  F Rusnak; P Mertz
Journal:  Physiol Rev       Date:  2000-10       Impact factor: 37.312

3.  Lack of nigral pathology in transgenic mice expressing human alpha-synuclein driven by the tyrosine hydroxylase promoter.

Authors:  Y Matsuoka; M Vila; S Lincoln; A McCormack; M Picciano; J LaFrancois; X Yu; D Dickson; W J Langston; E McGowan; M Farrer; J Hardy; K Duff; S Przedborski; D A Di Monte
Journal:  Neurobiol Dis       Date:  2001-06       Impact factor: 5.996

4.  α-Synuclein oligomers oppose long-term potentiation and impair memory through a calcineurin-dependent mechanism: relevance to human synucleopathic diseases.

Authors:  Zane S Martin; Volker Neugebauer; Kelly T Dineley; Rakez Kayed; Wenru Zhang; Lindsay C Reese; Giulio Taglialatela
Journal:  J Neurochem       Date:  2011-11-28       Impact factor: 5.372

5.  CHP2 activates the calcineurin/nuclear factor of activated T cells signaling pathway and enhances the oncogenic potential of HEK293 cells.

Authors:  Guo-Dong Li; Xi Zhang; Rong Li; Yue-Dan Wang; Yan-Li Wang; Ke-Jun Han; Xiao-Ping Qian; Cheng-Gang Yang; Ping Liu; Qun Wei; Wei-Feng Chen; Jun Zhang; Yu Zhang
Journal:  J Biol Chem       Date:  2008-09-24       Impact factor: 5.157

6.  A Drosophila model of Parkinson's disease.

Authors:  M B Feany; W W Bender
Journal:  Nature       Date:  2000-03-23       Impact factor: 49.962

7.  Ca2+ binding to alpha-synuclein regulates ligand binding and oligomerization.

Authors:  M S Nielsen; H Vorum; E Lindersson; P H Jensen
Journal:  J Biol Chem       Date:  2001-04-18       Impact factor: 5.157

8.  Distinct activation properties of the nuclear factor of activated T-cells (NFAT) isoforms NFATc3 and NFATc4 in neurons.

Authors:  Jason D Ulrich; Man-Su Kim; Patrick R Houlihan; Leonid P Shutov; Durga P Mohapatra; Stefan Strack; Yuriy M Usachev
Journal:  J Biol Chem       Date:  2012-09-12       Impact factor: 5.157

9.  Overexpression of human alpha-synuclein causes dopamine neuron death in primary human mesencephalic culture.

Authors:  Wenbo Zhou; Jerome Schaack; W Michael Zawada; Curt R Freed
Journal:  Brain Res       Date:  2002-02-01       Impact factor: 3.252

10.  Alpha-synuclein activation of protein phosphatase 2A reduces tyrosine hydroxylase phosphorylation in dopaminergic cells.

Authors:  Xiangmin Peng; Xiangmin M Peng; Roya Tehranian; Paula Dietrich; Leonidas Stefanis; Ruth G Perez
Journal:  J Cell Sci       Date:  2005-07-19       Impact factor: 5.285

View more
  31 in total

1.  Calcineurin Regulatory Subunit Calcium-Binding Domains Differentially Contribute to Calcineurin Signaling in Saccharomyces cerevisiae.

Authors:  Sean Connolly; Devona Quasi-Woode; Laura Waldron; Christian Eberly; Kerri Waters; Eric M Muller; Tami J Kingsbury
Journal:  Genetics       Date:  2018-05-07       Impact factor: 4.562

Review 2.  α-synuclein toxicity in neurodegeneration: mechanism and therapeutic strategies.

Authors:  Yvette C Wong; Dimitri Krainc
Journal:  Nat Med       Date:  2017-02-07       Impact factor: 53.440

3.  Trim39 regulates neuronal apoptosis by acting as a SUMO-targeted E3 ubiquitin-ligase for the transcription factor NFATc3.

Authors:  Meenakshi Basu-Shrivastava; Barbara Mojsa; Stéphan Mora; Ian Robbins; Guillaume Bossis; Iréna Lassot; Solange Desagher
Journal:  Cell Death Differ       Date:  2022-04-21       Impact factor: 15.828

Review 4.  A central role for calcineurin in protein misfolding neurodegenerative diseases.

Authors:  Syed Zahid Ali Shah; Tariq Hussain; Deming Zhao; Lifeng Yang
Journal:  Cell Mol Life Sci       Date:  2016-09-28       Impact factor: 9.261

5.  Peptides derived from transcription factor EB bind to calcineurin at a similar region as the NFAT-type motif.

Authors:  Ruiwen Song; Jing Li; Jin Zhang; Lu Wang; Li Tong; Ping Wang; Huan Yang; Qun Wei; Huaibin Cai; Jing Luo
Journal:  Biochimie       Date:  2017-09-07       Impact factor: 4.079

6.  A novel peptide exerts potent immunosuppression by blocking the two-site interaction of NFAT with calcineurin.

Authors:  Lu Wang; Na Cheng; Ping Wang; Jing Li; Anna Jia; Wenying Li; Nan Zhang; Yanxia Yin; Li Tong; Qun Wei; Guangwei Liu; Zhimei Li; Jing Luo
Journal:  J Biol Chem       Date:  2020-01-15       Impact factor: 5.157

7.  Neuronal-targeted TFEB rescues dysfunction of the autophagy-lysosomal pathway and alleviates ischemic injury in permanent cerebral ischemia.

Authors:  Yueyang Liu; Xue Xue; Haotian Zhang; Xiaohang Che; Jing Luo; Ping Wang; Jiaoyan Xu; Zheng Xing; Linlin Yuan; Yinglu Liu; Xiaoxiao Fu; Dongmei Su; Shibo Sun; Haonan Zhang; Chunfu Wu; Jingyu Yang
Journal:  Autophagy       Date:  2018-10-18       Impact factor: 16.016

Review 8.  Aldehyde Dehydrogenase 1 making molecular inroads into the differential vulnerability of nigrostriatal dopaminergic neuron subtypes in Parkinson's disease.

Authors:  Huaibin Cai; Guoxiang Liu; Lixin Sun; Jinhui Ding
Journal:  Transl Neurodegener       Date:  2014-12-10       Impact factor: 8.014

9.  LRRK2 mediates microglial neurotoxicity via NFATc2 in rodent models of synucleinopathies.

Authors:  Changyoun Kim; Alexandria Beilina; Nathan Smith; Yan Li; Minhyung Kim; Ravindran Kumaran; Alice Kaganovich; Adamantios Mamais; Anthony Adame; Michiyo Iba; Somin Kwon; Won-Jae Lee; Soo-Jean Shin; Robert A Rissman; Sungyong You; Seung-Jae Lee; Andrew B Singleton; Mark R Cookson; Eliezer Masliah
Journal:  Sci Transl Med       Date:  2020-10-14       Impact factor: 17.956

Review 10.  To Ubiquitinate or Not to Ubiquitinate: TRIM17 in Cell Life and Death.

Authors:  Meenakshi Basu-Shrivastava; Alina Kozoriz; Solange Desagher; Iréna Lassot
Journal:  Cells       Date:  2021-05-18       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.